Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Mater Sci Mater Med ; 32(9): 109, 2021 Aug 28.
Article in English | MEDLINE | ID: mdl-34453621

ABSTRACT

The aim of this study was to evaluate biocompatibility of hydroxyapatite (HAP) from fish waste using in vitro and in vivo assays. Fish samples (whitemouth croaker - Micropogonias furnieri) from the biowaste was used as HAP source. Pre-osteoblastic MC3T3-E1 cells were used in vitro study. In addition, bone defects were artificially created in rat calvaria and filled with HAP in vivo. The results demonstrated that HAP reduced cytotoxicity in pre-osteoblast cells after 3 and 6 days following HAP exposure. DNA concentration was lower in the HAP group after 6 days. Quantitative RT-PCR did not show any significant differences (p > 0.05) between groups. In vivo study revealed that bone defects filled with HAP pointed out moderate chronic inflammatory cells with slight proliferation of blood vessels after 7 and 15 days. Chronic inflammatory infiltrate was absent after 30 days of HAP exposure. There was also a decrease in the amount of biomaterial, being followed by newly formed bone tissue. All experimental groups also demonstrated strong RUNX-2 immoexpression in the granulation tissue as well as in cells in close contact with biomaterial. The number of osteoblasts inside the defect area was lower in the HAP group when compared to control group after 7 days post-implantation. Similarly, the osteoblast surface as well as the percentage of bone surface was higher in control group when compared with HAP group after 7 days post-implantation. Taken together, HAP from fish waste is a promising possibility that should be explored more carefully by tissue-engineering or biotechnology.


Subject(s)
Durapatite/isolation & purification , Durapatite/pharmacology , Fish Products , Animals , Bone Regeneration/drug effects , Bone Substitutes/chemistry , Bone Substitutes/isolation & purification , Bone Substitutes/pharmacology , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Fish Products/analysis , Materials Testing , Mice , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoblasts/physiology , Osteogenesis/drug effects , Perciformes , Rats , Skull/drug effects , Skull/physiology , Solid Waste/analysis
2.
Mar Biotechnol (NY) ; 21(1): 65-75, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30443837

ABSTRACT

Bone fractures characterize an important event in the medical healthcare, being related to traumas, aging, and diseases. In critical conditions, such as extensive bone loss and osteoporosis, the tissue restoration may be compromised and culminate in a non-union consolidation. In this context, the osteogenic properties of biomaterials with a natural origin have gained prominence. Particularly, marine sponges are promising organisms that can be exploited as biomaterials for bone grafts. Thus, the objectives of this study were to study the physicochemical and morphological properties of biosilica (BS) from sponges by using scanning electron microscopy, Fourier-transform infrared, X-ray diffraction (SEM, FTIR and XRD respectively), mineralization, and pH. In addition, tests on an osteoblast precursor cell line (MC3T3-E1) were performed to investigate its cytotoxicity and proliferation in presence of BS. Bioglass (BG) was used as gold standard material for comparison purposes. Sponge BS was obtained, and this fact was proven by SEM, FTIR, and XRD analysis. Calcium assay showed a progressive release of this ion from day 7 and a more balanced pH for BS was maintained compared to BG. Cytotoxicity assay indicated that BS had a positive influence on MC3T3-E1 cells viability and qRT-PCR showed that this material stimulated Runx2 and BMP4 gene expressions. Taken together, the results indicate a potential use of sponge biosilica for tissue engineering applications.


Subject(s)
Biocompatible Materials/pharmacology , Bone Substitutes/pharmacology , Osteoblasts/drug effects , Porifera/chemistry , Silicon Dioxide/pharmacology , Animals , Biocompatible Materials/isolation & purification , Biomarkers/metabolism , Bone Morphogenetic Protein 4/genetics , Bone Morphogenetic Protein 4/metabolism , Bone Substitutes/isolation & purification , Bone and Bones/cytology , Bone and Bones/drug effects , Bone and Bones/metabolism , Cell Line , Cell Proliferation/drug effects , Cell Survival/drug effects , Core Binding Factor Alpha 1 Subunit/genetics , Core Binding Factor Alpha 1 Subunit/metabolism , Fractures, Bone/therapy , Gene Expression , Humans , Mice , Osteoblasts/cytology , Osteoblasts/metabolism , Silicon Dioxide/isolation & purification , Tissue Engineering/methods
SELECTION OF CITATIONS
SEARCH DETAIL